About ACT

Advanced Cardiac Therapeutics, Inc. is a pre-commercial, medical device company that designs and manufactures a catheter-based system for the treatment of patients with AFIB.  AFIB is characterized by an irregular, often rapid heart rate that commonly causes poor systemic blood flow. The Company's mission is to dramatically improve the treatment of AFIB through the introduction of products based on its proprietary catheter and generator system.  ACT’s technology is the only system in the world to leverage feedback from four unique capabilities:  temperature sensing, low irrigation flow rates, high resolution EGM attenuation and contact sensing.  The ACT system is not currently approved for commercial use.  For more information, please contact us at info@actmed.net.

 

© 2016 Advanced Cardiac Therapeutics. All Rights Reserved.

The ACT cardiac ablation catheter is not available for sale.  Investigational Use Only.

.......................................................................................................................................................................